skip to content

Cancer prevalence in {{ccg16nm}}

At the end of {{prevalence_year}}, around {{full_prevalence_duration}} people in {{ccg16nm}} were living up to 24 years after a cancer diagnosis. This could rise to an estimated {{projection_prevalence_rounded}} by {{projection_year}}.

 

What can this show?

Cancer prevalence indicates the size of the population living with cancer and shows how these numbers vary for different cancer types. Prevalence can reflect trends in cancer incidence, mortality and survival, as well as advances in cancer treatment and detection, and the ageing of the population.

What is prevalence?

Prevalence is the number of cases of a disease that are present in a particular population at a given time.

Learn more about prevalence.

How many people are living with cancer at different time periods after their initial diagnosis?

People’s needs change during their cancer. Local data for different cancer types are shown below. This gives an indication of the total demand for care at different times after diagnosis and can be an alternative way to look at length of survival. Cancers such as lung cancer have proportionally fewer long-term survivors whereas breast cancer has proportionally more.

The ' download icon ' symbol below right allows you to print or download the chart in various formats.

Data release dates

This 2016 prevalence data set was released in March 2018.

The next prevalence release for 2017 data is planned for March 2019.

Projected prevalence

The above chart shows two possible future scenarios:

  • Scenario 1: Assumes people will continue to get and survive cancer at increasing rates in line with recent trends (except for prostate cancer), and the general population will continue to grow and age.
  • Scenario 2: Assumes people will continue to get cancer at the rate they do today, and that survival rates will remain as they are. The estimates are therefore driven by a growing and ageing population only.

Note: As with all projections, these estimates serve as indicators and are likely to change as more data becomes available. The estimates are very crude, as they are based on a UK-wide growth rate in total prevalence.

They do not take into account differences between Northern Ireland and the rest of the UK or variations across areas within Northern Ireland. Differences and changes in the age, sex and cancer profile, deprivation profile, migration, cancer risk factors, screening programmes or treatment regimes, can all influence prevalence, but they have not impacted these predictions.

Being told ‘you have cancer’ can affect so much more than your health. But we are here to help everyone with cancer live life as fully as they can.

To get involved, donate, volunteer, or campaign, call 0300 1000 200 today or visit macmillan.org.uk/get-involved